Protein lập trình được thiết kế “có logic” mới giúp tăng độ chính xác trong việc đưa thuốc tới tế bào mục tiêu, mở ra triển vọng mới cho y học cá nhân hoá và điều trị thông minh. #SyntheticBiology #ProteinEngineering #DrugDelivery #YHọc #CôngNghệSinhHọc #PrecisionMedicine #CôngNghệ #KhoaHoc
(Note: No URL included)
Carnegie Mellon University scientists have engineered microscopic robots, called AggreBots, using human lung cells. These bio-robots move with cilia, the tiny hairlike structures that naturally propel particles in the lungs. Researchers demonstrated for the first time that cilia-driven biological robots can be guided with precision. Published in Science Advances, this work opens new possibilities for targeted drug delivery, minimally invasive therapies, and future biomedical innovations. The approach shows how human cells can be re-engineered into active therapeutic tools, advancing the next generation of medical treatments.
Core discovery & science
#MedicalBreakthrough #BioRobotics #LifeSciences #FutureOfMedicine #ScienceAdvances
Technology & innovation
#AggreBots #CellEngineering #TargetedTherapy #DrugDelivery #MinimallyInvasive #Biotech
Impact & applications
#InnovativeMedicine #NextGenHealthcare #CuttingEdgeScience #BiomedicalEngineering #HealthTech
The microfluidic components market is experiencing significant growth, expected to reach USD 12.17 billion by 2032.
🔹 Top Companies:
Danaher Corporation
Illumina Inc.
PerkinElmer Inc.
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Thermo Fisher Scientific Inc.
For detailed insights, view the full report: https://www.credenceresearch.com/report/microfluidic-components-market
#Microfluidics #HealthcareInnovation #Diagnostics #MarketGrowth #LifeSciences #MedicalDevices #PointOfCare #DrugDelivery #MicrofluidicComponents
#ActaMateriaMedica: 'Innovations and challenges in bioresponsive materials for effective drug delivery in diabetes mellitus' - an article on #ScienceOpen 🔓📄🔗 https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2025-0020
#BioresponsiveMaterials #GlucoseResponsive #DrugDelivery #DiabetesResearch #Nanomedicine
<p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d3937504e128">Bioresponsive materials have gained prominence as innovative tools for advancing drug delivery systems, particularly in managing type 1 and type 2 diabetes mellitus. These materials respond to biological stimuli such as pH, glucose, enzymes, or temperature, thereby enabling spatiotemporally controlled drug release. This review examines recent progress in the design strategies, activation mechanisms, and therapeutic applications of these materials in diabetes care. Key focus areas include macromolecular insulin delivery systems and oral hypoglycemic agents, with emphasis on their efficacy in regulating blood glucose homeostasis. Despite their promise, challenges persist in translating these technologies to clinical practice, including scalability limitations, insufficient clinical validation, regulatory hurdles, and healthcare system compatibility. Current therapeutic shortcomings, such as frequent injections and adverse effects compromising patient adherence, are discussed. By synthesizing contemporary research developments and implementation barriers, this work provides critical insights into optimizing bioresponsive platforms for clinical translation. Our analysis underscores the need for interdisciplinary approaches to address technical and practical constraints, and ultimately engineer patient-centric, scalable solutions that enhance therapeutic outcomes and quality of life. Future directions include bridging material innovation with clinical needs to develop next-generation diabetes management systems. </p>
Starting TODAY 📅 Aug 5, 2025, at 🕞 3:30 pm CEST: Online #BeilsteinTalk “Next-generation drug and vaccine delivery for global health” with Ana Jaklenec from the Massachusetts Institute of Technology.
There’s still time to register for FREE 🔗 https://www.beilstein-institut.de/en/talks/nanotechnology-next-generation-drug-and-vaccine-delivery-for-global-health/?M=y
#DrugDelivery #vaccines #GlobalHealth #CancerImmunotherapy #BeilsteinTalks
Invitation to join the online #BeilsteinTalk “Next-generation drug and vaccine delivery for global health” with Ana Jaklenec from the Massachusetts Institute of Technology on 📅 Aug 5, 2025, 🕞 3:30–4:30 pm CEST.
Participation is FREE – just register 🔗 https://www.beilstein-institut.de/en/talks/nanotechnology-next-generation-drug-and-vaccine-delivery-for-global-health/?M=y
#DrugDelivery #vaccines #GlobalHealth #CancerImmunotherapy #BeilsteinTalks
Save the date: 📅 Aug 5, 2025 🕞 3:30–4:30 pm CEST
Online #BeilsteinTalk “Next-generation drug and vaccine delivery for global health” with Ana Jaklenec from the Massachusetts Institute of Technology.
Register for FREE! 🔗 https://www.beilstein-institut.de/en/talks/nanotechnology-next-generation-drug-and-vaccine-delivery-for-global-health/?M=y
#DrugDelivery #vaccines #GlobalHealth #CancerImmunotherapy #BeilsteinTalks
HackerNews VN bot
Lexmilian S. R. B. de Mello
Beilstein-Institut
Credence Research Europe LTD
ScienceOpen
Newsramp